Literature DB >> 27432407

Objective structured clinical examination for pharmacy students in Qatar: cultural and contextual barriers to assessment.

K J Wilby1, E K Black2, Z Austin3, B Mukhalalati1, S Aboulsoud4, S I Khalifa1.   

Abstract

This study aimed to evaluate the feasibility and psychometric defensibility of implementing a comprehensive objective structured clinical examination (OSCE) on the complete pharmacy programme for pharmacy students in a Middle Eastern context, and to identify facilitators and barriers to implementation within new settings. Eight cases were developed, validated, and had standards set according to a blueprint, and were assessed with graduating pharmacy students. Assessor reliability was evaluated using inter-class coefficients (ICCs). Concurrent validity was evaluated by comparing OSCE results to professional skills course grades. Field notes were maintained to generate recommendations for implementation in other contexts. The examination pass mark was 424 points out of 700 (60.6%). All 23 participants passed. Mean performance was 74.6%. Low to moderate inter-rater reliability was obtained for analytical and global components (average ICC 0.77 and 0.48, respectively). In conclusion, OSCE was feasible in Qatar but context-related validity and reliability concerns must be addressed prior to future iterations in Qatar and elsewhere.

Entities:  

Mesh:

Year:  2016        PMID: 27432407     DOI: 10.26719/2016.22.4.251

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  2 in total

1.  Pass-Fail Decisions for Borderline Performers After a Summative Objective Structured Clinical Examination.

Authors:  Mayar Ali; Shane A Pawluk; Daniel C Rainkie; Kyle John Wilby
Journal:  Am J Pharm Educ       Date:  2019-03       Impact factor: 2.047

2.  Evolving to Objective Structured Clinical Exams (OSCE): Transitional experience in an undergraduate pharmacy program in Kuwait.

Authors:  Asmaa Al-Haqan; Dalal Al-Taweel; Samuel Koshy; Sarah Alghanem
Journal:  Saudi Pharm J       Date:  2020-12-29       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.